Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.25 (
MEKK1
)
1,856
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Receptor-interacting protein (RIP) plays a critical role in tumor necrosis factor alpha (TNF-alpha)-induced NF-kappaB activation. However, the mechanism by which RIP mediates TNF-alpha-induced signal transduction is not fully understood. In this study, we reconstituted RIP-deficient Jurkat T cells with a fusion protein composed of full-length
MEKK3
and the death domain of RIP (MEKK3-DD). In these cells,
MEKK3
-DD substitutes for RIP and directly associates with TRADD in TNF receptor complexes following TNF-alpha stimulation. We found that TNF-alpha-induced NF-kappaB activation was fully restored by
MEKK3
-DD in these cells. In contrast, expression of a fusion protein composed of NEMO, a component of the IkappaB kinase complex, and the death domain of RIP (NEMO-DD) cannot restore TNF-alpha-induced NF-kappaB activation in RIP-deficient cells. These results indicate that the role of RIP is to specifically recruit
MEKK3
to the TNF-alpha receptor complex, whereas the forced recruitment of NEMO to the TNF-alpha receptor complex is insufficient for TNF-alpha-induced NF-kappaB activation. Although
MEKK2
has a high degree of homology with
MEKK3
,
MEKK2
-DD, unlike
MEKK3
-DD, also fails to restore TNF-alpha-induced NF-kappaB activation in RIP-deficient cells, indicating that RIP-dependent recruitment of
MEKK3
plays a specific role in TNF-alpha signaling.
...
PMID:Restoration of NF-kappaB activation by tumor necrosis factor alpha receptor complex-targeted MEKK3 in receptor-interacting protein-deficient cells. 1557 79
Mitogen-activated protein kinase (MAPK) cascades are the central components of the intracellular signaling networks that eukaryotic cells use to respond to a wide spectrum of extracellular stimuli. MAPKs are activated through a module consisting of a MAPK, a MAPK kinase (MKK), and a MKK kinase (
MAP3K
). Because of its unique position in the MAPK module, a
MAP3K
is crucial in relaying the upstream receptor-mediated signals through the MAPK cascades to induce physiological responses. Yet, the underlying molecular mechanism of
MAP3K
regulation and activation remains largely unknown. In this study, we demonstrated that
MAP3K
MEKK2
activation requires dimerization. We mapped the
MEKK2
dimerization motif in its catalytic domain and showed that the NH2-terminal region is not required for
MEKK2
dimer formation. We also found that the inactive, non-phosphorylated
MEKK2
formed significantly more dimers than the phosphorylated and, hence, active
MEKK2
. Moreover, prevention of
MEKK2
dimer formation inhibited
MEKK2
-mediated JNK activation. Using a chemical-induced dimerization system, we further demonstrated that
MEKK2
dimer formation in vivo augmented
MEKK2
-dependent JNK activation and JNK/AP-1 reporter gene transcription. Together, these results suggest a novel mechanism underlying
MEKK2
regulation and activation.
...
PMID:Dimerization through the catalytic domain is essential for MEKK2 activation. 1569 8
Bone is constantly resorbed and formed throughout life by coordinated actions of osteoclasts and osteoblasts. Here we show that Smurf1, a HECT domain ubiquitin ligase, has a specific physiological role in suppressing the osteogenic activity of osteoblasts. Smurf1-deficient mice are born normal but exhibit an age-dependent increase of bone mass. The cause of this increase can be traced to enhanced activities of osteoblasts, which become sensitized to bone morphogenesis protein (BMP) in the absence of Smurf1. However, loss of Smurf1 does not affect the canonical Smad-mediated intracellular TGFbeta or BMP signaling; instead, it leads to accumulation of phosphorylated
MEKK2
and activation of the downstream JNK signaling cascade. We demonstrate that Smurf1 physically interacts with
MEKK2
and promotes the ubiquitination and turnover of
MEKK2
. These results indicate that Smurf1 negatively regulates osteoblast activity and response to BMP through controlling
MEKK2
degradation.
...
PMID:Ubiquitin ligase Smurf1 controls osteoblast activity and bone homeostasis by targeting MEKK2 for degradation. 1582 Jun 71
Mitogen-activated protein kinase (MAPK) cascades are central components of the intracellular signaling networks used by eukaryotic cells to respond to a wide spectrum of extracellular stimuli. An MAPK is activated by an MAPK kinase, which in turn is activated by an MAPK kinase kinase (
MAP3K
). However, little is known about the molecular aspects of the regulation and activation of large numbers of MAP3Ks that are crucial in relaying upstream receptor-mediated signals through the MAPK cascades to induce various physiological responses. In this study, we identified a novel
MEKK2
-interacting protein, Mip1, that regulates
MEKK2
dimerization and activation by forming a complex with inactive and nonphosphorylated
MEKK2
. In particular, Mip1 prevented
MEKK2
activation by blocking
MEKK2
dimer formation, which in turn blocked JNKK2, c-Jun N-terminal kinase 1 (JNK1), extracellular signal-regulated kinase 5, and AP-1 reporter gene activation by
MEKK2
. Furthermore, we found that the endogenous Mip1-
MEKK2
complex was dissociated transiently following epidermal growth factor stimulation. In contrast, the knockdown of Mip1 expression by siRNA augmented the
MEKK2
-mediated JNK and AP-1 reporter activation. Together, our data suggest a novel model for
MEKK2
regulation and activation.
...
PMID:Mip1, an MEKK2-interacting protein, controls MEKK2 dimerization and activation. 1598 11
The alternative splicing of the mek5 gene gives rise to two isoforms. MEK5beta lacks an extended N terminus present in MEK5alpha. Comparison of their activities led us to identify a novel mitogen-activated protein kinase (MAPK) docking site in the N terminus of MEK5alpha that is distinct from the consensus motif identified in the other MAPK kinases. It consists of a cluster of acidic residues at position 61 and positions 63 to 66. The formation of the MEK5/extracellular signal-regulated kinase 5 (ERK5) complex is critical for MEK5 to activate ERK5, to increase transcription via MEF2, and to enhance cellular survival in response to osmotic stress. Certain mutations in the ERK5 docking site that prevent MEK5/ERK5 interaction also abrogate the ability of
MEKK2
to bind and activate MEK5. However, the identification of MEK5alpha mutants with selective binding defect demonstrates that the MEK5/ERK5 interaction does not rely on the binding of MEK5alpha to
MEKK2
via their respective PB1 domains. Altogether these results establish that the N terminus of MEK5alpha is critical for the specific organization of the components of the ERK5 signaling pathway.
...
PMID:A novel mitogen-activated protein kinase docking site in the N terminus of MEK5alpha organizes the components of the extracellular signal-regulated kinase 5 signaling pathway. 1626 May 99
Members of the
mitogen-activated protein kinase kinase kinase
(
MAP3K
) family are crucial for the Toll-like receptor (TLR) signaling and cellular stress responses. However, the molecular mechanisms underlying the TLR- and cellular stress-mediated
MAP3K
activation remain largely unknown. In this study, we identified a key regulatory phosphorylation site, serine 519 and serine 526, in
MAP3K
MEKK2
and
MEKK3
, respectively. Mutation of this serine to an alanine severely impaired
MEKK2
/3 activation. We generated an anti-p-
MEKK2
/3 antibody and used this antibody to demonstrate that lipopolysaccharide induced
MEKK2
and
MEKK3
phosphorylation on their regulatory serine. We found that the serine phosphorylation was crucial for TLR-induced interleukin 6 production and this process is regulated by TRAF6, a key adaptor molecule for the TLR pathway. We further demonstrated that many, but not all, MAPK agonists induced the regulatory serine phosphorylation, suggesting an involvement of different MAP3Ks in activation of the MAPK cascades leading to different cellular responses. In conclusion, this study reveals a novel molecular mechanism for
MEKK2
/3 activation by the TLR and cellular stress pathways.
...
PMID:Identification of MEKK2/3 serine phosphorylation site targeted by the Toll-like receptor and stress pathways. 1636 41
Regulation of MAPK pathways by PKC isoforms was examined in murine bone marrow-derived mast cells (BMMCs). The PKCalpha, betaI, and betaII isoforms showed the most robust activation after FcepsilonR1-mediated stimulation by anti-ovalbumin specific IgE and ovalbumin (IgE-ova). PKCalpha, betaI, and betaII were all involved in activation of JNK,
MEKK2
, and ERK5, with differential relative contributions of each isoform to specific MAPK pathway components. BMMCs from mice lacking
MEKK2
showed reduced production (50-60%) of IL-6, IL-13, and TNF-alpha after stimulation, demonstrating
MEKK2
-dependent and -independent pathways for cytokine production. Cytokine production was stimulated by over-expression of PKC in cells from
MEKK2
-deficient and wild-type mice. Activation of ERK5 did not occur in BMMCs lacking
MEKK2
, indicating that
MEKK2
-independent cytokine production was also ERK5-independent. Since MAPK modules differentially regulate mast cell functions, including degranulation and cytokine production, it is suggested that specific functions could be targeted by inhibiting specific PKC isoforms.
...
PMID:Protein kinase C alpha, betaI, and betaII isozymes regulate cytokine production in mast cells through MEKK2/ERK5-dependent and -independent pathways. 1643 Aug 78
Ectodomain shedding of the amyloid precursor protein (APP) is a key regulatory step in the generation of the amyloid beta peptide (Abeta), which is thought to provoke the pathogenesis of Alzheimer's disease. To better understand the cellular processes that regulate ectodomain shedding of APP we used human embryonic kidney 293 cells and applied a sib-selection expression cloning approach. In addition to a known activator of APP shedding -- protein kinase A -- the following cDNAs were identified: the endocytic proteins endophilin A1 and A3, the metabotropic glutamate receptor 3 (mGluR3), palmitoyl-protein thioesterase 1 (PPT1), Numb-like and the kinase
MEKK2
. Endophilins A1 and A3, as well as mGluR3 activated APP shedding relatively specifically. They had little or no effect on the shedding of the unrelated membrane proteins TNF receptor 2 and P-selectin glycoprotein ligand-1. In contrast,
MEKK2
and PKA also increased shedding of TNF receptor 2, suggesting that these kinases contribute to a general program regulating ectodomain shedding. The strongest activator of APP shedding, endophilin A3, reduced the rate of APP endocytosis and specifically increased APP shedding by the protease alpha-secretase, as measured in an antibody uptake assay and by immunoblot analysis. This suggests that endophilin A3 is a novel modulator of APP trafficking affecting access of APP to alpha-secretase. In summary, this study shows that expression cloning is a suitable way to identify proteins controlling ectodomain shedding of membrane proteins.
...
PMID:Expression cloning screen for modifiers of amyloid precursor protein shedding. 1644 73
MEKK2
, MEK5, and extracellular signal-regulated kinase 5 (ERK5) are members of a three-kinase cascade for the activation of ERK5. MEK5 is the only MAP2K to express a PB1 domain, and we have shown that it heterodimerizes with the PB1 domain of
MEKK2
. Here we demonstrate the MEK5 PB1 domain is a scaffold that also binds ERK5, functionally forming a
MEKK2
-MEK5-ERK5 complex. Reconstitution assays and CFP/YFP imaging (fluorescence resonance energy transfer [FRET]) measuring YFP-
MEKK2
/CFP-MEK5 and CFP-MEK5/YFP-ERK5 interactions define distinct MEK5 PB1 domain binding sites for
MEKK2
and ERK5, with a C-terminal extension of the PB1 domain contributing to ERK5 binding. Stimulus-dependent CFP/YFP FRET in combination with mutational analysis was used to define MEK5 PB1 domain residues critical for the interaction of
MEKK2
/MEK5 and MEK5/ERK5 required for activation of the ERK5 pathway in living cells. Fusion of the MEK5 PB1 domain to the N terminus of MEK1 confers ERK5 regulation by a MAP2K normally regulating only ERK1/2. The MEK5 PB1 domain confers stringent
MAP3K
regulation of ERK5 relative to more promiscuous
MAP3K
control of ERK1/2, JNK, and p38.
...
PMID:PB1 domain-dependent signaling complex is required for extracellular signal-regulated kinase 5 activation. 1650 87
Cells integrate signals to select the appropriate response from an array of possible outcomes. Signal integration causes the reorganization of signaling pathways by undescribed events. To analyze the molecular changes in signaling pathways that elicit different responses, we focused on the interaction between cyclic AMP (cAMP) and growth factors. We show that the activation of extracellular signal-regulated kinase 5 (ERK5), but not ERK1/2, by growth factors is disrupted by cAMP through cAMP-dependent protein kinase (PKA). Activation of
MEKK2
, a mitogen-activated protein (MAP) kinase kinase kinase upstream of ERK5 that is required for growth factor activation of ERK5, is also disrupted by PKA. Transcription of c-Jun is induced by ERK5, and like ERK5, c-Jun induction is also blocked by cAMP. Transcription from the serum response element, like activation of ERK1/2, is not blocked by cAMP. Collectively, these results support a model in which cAMP shapes the growth factor-induced cellular response through PKA-dependent uncoupling of selected MAP kinase cascades from activating signals.
...
PMID:Cyclic AMP selectively uncouples mitogen-activated protein kinase cascades from activating signals. 1658 79
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>